Achira builds atomistic foundation simulation models for drug discovery. The company's work sits at the intersection of machine learning, quantum chemistry, geometric deep learning, physics, and statistical mechanics. Its team comprises machine learners, quantum chemists, engineers, and computer-aided drug discovery practitioners.
The company was founded on the view that existing approaches to biomolecular simulation are technologically limited and poorly suited to exploit large increases in computing power. Achira describes its approach as a third path, combining the rigor of physics-based simulation with the flexibility of modern machine learning methods to generate a fundamentally new way of discovering therapeutic compounds.
